
Yonghua Capital
Description
Yonghua Capital (涌铧投资), headquartered in Shanghai, China, stands as one of the country's pioneering private equity and venture capital firms, having been established in 2000. With a long-standing presence in the Chinese investment landscape, the firm has evolved to become a significant player, primarily focusing on growth-stage and pre-IPO investments across a diverse range of high-growth sectors. Its strategic location in Shanghai positions it at the heart of China's economic and technological innovation hubs, allowing it to tap into a wide array of promising opportunities.
The firm manages multiple funds, encompassing both RMB and USD denominated capital, with its assets under management (AUM) reportedly exceeding tens of billions of RMB. Some estimates place their AUM at over 30 billion RMB, which translates to approximately $4.2 billion USD, underscoring their substantial financial capacity. Yonghua Capital's investment philosophy centers on identifying and nurturing companies with strong growth potential, providing not only capital but also strategic guidance to help portfolio companies scale and prepare for public listings or strategic exits.
Yonghua Capital's investment mandate spans several key industries critical to China's economic development, including Technology, Media, and Telecommunications (TMT), healthcare, advanced manufacturing, new energy, and consumer services. The firm boasts a robust track record of successful exits, particularly through initial public offerings (IPOs), having facilitated the listing of numerous companies on various stock exchanges. Typical first check sizes for Yonghua Capital range from approximately $1.4 million USD to $71.4 million USD, reflecting their focus on significant growth rounds and their capacity to lead or co-lead substantial funding rounds for mature startups and pre-IPO companies. This broad investment range allows them to support companies from later-stage venture rounds through to pre-listing stages, making them a versatile partner for ambitious enterprises.
Investor Profile
Yonghua Capital has backed more than 28 startups, with 7 new investments in the last 12 months alone. The firm has led 4 rounds, about 14% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in China, United States, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 1 rounds in the past year.
- Typical check size: $1.4M – $71.4M.
Stage Focus
- Series A (36%)
- Series B (21%)
- Series Unknown (11%)
- Series C (11%)
- Angel (7%)
- Seed (7%)
- Series E (4%)
- Series D (4%)
Country Focus
- China (57%)
- United States (36%)
- United Kingdom (4%)
- Belgium (4%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Biopharma
- Pharmaceutical
- Manufacturing
- Therapeutics
- Medical Device
- Health Diagnostics
- Education
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.